Latest news

Keep up to date with our latest articles detailing updates on our data and visualisation services and providing key insight into healthcare data, especially for pharma companies looking to monitor medicines and markets.


Example of how we use Treemaps to quickly visualise data.

This example visual shows the "Brand vs Generic" prescription costs data for all Primary Care Organisations in the UK for the latest 12 months. Each PCO is sized by the Net Ingredient Cost.

The use of a Tableau Treemap makes it easier to quickly scan across the visual and see which PCOs prescribed predominantly by Brand or generically.

Contact us to find out more

Visual Numbers is creating in depth market analysis reports to help customers better understand specific markets over time.

The example visual shows the "Drugs used in Diabetes" prescription costs analysis (PCA) data for all diabetes drug category costs in England from 2004 to 2019. It is fascinating to see how different drugs have emerged in this market to help diabetic T1 and T2 patients better manage their diabetes.

This is an area Visual Numbers is keen to assist Pharma as NHS England projection figures predict that there will be almost 5 million diabetic patients by the year 2035. (© Public Health England, 2016. National Cardiovascular Intelligence Network Prevalence estimates of diabetes)

Contact us to find out more

Visual Numbers has just created an interactive map workbook with the latest NHS England structures and is offering this FOC to help Pharma sales and marketing professionals in these unusual times.

The interactive map workbook enables you to see all 1,259 PCNs, 6,725 GP Practices sorted by 42 STP and respective 135 CCG structures. The workbook can be viewed using free downloadable 'Tableau Reader' software. 

Contact us to find out more

Whilst we are all in this current situation, Visual Numbers is offering a cost effective visuals which map out all PCOs  in England, N Ireland, Scotland and Wales and enables you to see 'top 20 PCO' potentials in the dashboard visual. 

Additionally we have the capability to map the new 'Sustainability and transformation partnerships' (STP) structures and can also group the latest Primary Care Network (PCN) groupings to help you focus your business in alignment with these new NHS structures moving ahead.

Available as PDF reports for overview snapshots or interactive Tableau packaged workbooks for detailed insights.

Contact us to find out more

RxAISE is a service from VISUAL NUMBERS which offers exceptionally cost-effective prescription sales reports for National, Regional, Territory, CCG and GP practice level analysis of Sales value and volume for your product and that of your competitors.

These reports are ideal for small to medium sized Pharmaceutical and Healthcare sales teams looking for a cost-effective sales reporting solution. Additionally, they are perfect for CSO syndicated sales teams where they do not receive sales data. Also, they can be purchased by individual representatives and organisations (such as marketing and recruitment agencies) looking for further prescription sales detail at either a UK nationwide level or down to territory, CCG or even GP practice level.

Available as PDF reports for overview snapshots or interactive Tableau packaged workbooks for detailed insights.

Contact us to find out more

Visual Numbers is currently working with a leading Augmented Intelligence software solutions provider - Squirro - to explore how Pharmaceutical and Healthcare companies can gain better customer insights and improve gathering, analysing and structuring data.

As a result this will  accelerate the business decision process with more valuable information being to hand. Also it will improve customer service and assist businesses to keep ahead of competitors.

Will 2019 be the year in which pharma sales and marketing teams use augmented intelligence to successfully exploit infinite data?
Read our article in the January 2019 edition of Pharmafield (pages 12-14).

Want to know what the keys to success are when launching a Category C branded generic?
Read our article in the September 2018 edition of Pharmafield (pages 26-28).